Clare Cutland is the Scientific Coordinator of the African Leadership in Vaccinology Expertise (ALIVE) consortium. Prior to her appointment in ALIVE (Nov 2018), she was a research medical officer and subsequently the deputy director of the Respiratory and Meningeal Pathogens Research Unit (RMPRU), based at Chris Hani Baragwanath Academic Hospital (CHBAH), Soweto, South Africa (2000-2018).

She was an investigator on numerous phase I, II and III paediatric and maternal vaccine trials and principal investigator on a phase II paediatric measles vaccine trial, a phase III quadrivalent influenza vaccine trial in children and a phase III maternal influenza immunization trial in HIV-positive women. Clare Cutland was the clinical lead for several large grant-funded neonatal sepsis prevention (PoPS, sepsis surveillance) and maternal immunization studies (influenza, Streptococcus agalactiae sero-correlate of protection) and an investigator on numerous maternal immunization trials (GBS, RSV), and has described several challenges and lessons learnt in maternal immunization trials. She was involved in the GAIA Brighton collaboration definition working groups (2014-2016), and was elected as a member of the scientific board of the Brighton collaboration in 2018.